CLOVER HEALTH INVESTMENTS, CORP. /DE
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a) The Financial Statements, Financial Statement Schedules, and exhibits set forth below are filed as part of this Form 10-K.
(1) Financial Statements-The response to this portion of Item 15 is submitted as Item 8 of Part II of this Form 10-K.
(2) Financial Statement Schedules-The response to this portion of Item 15 is submitted as Item 8 of Part II of this Form 10-K.
(3) A list of exhibits to this Form 10-K is set forth below:
| Incorporated by reference | |||||
|---|---|---|---|---|---|
| ExhibitNo. · Description · Form · File No. · Exhibit No. · Filing date · Filed or Furnished herewith | |||||
| 2.1** | Agreement and Plan of Merger, dated as of October 5, 2020, by and among the Registrant, Asclepius Merger Sub Inc. and Clover Health Investments, Corp. | 8-K | 001-39252 | 2.1 | 10/06/2020 |
| 2.1(a) | Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020 | 8-K | 001-39252 | 2.1 | 12/10/2020 |
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant | 8-K | 001-39252 | 3.1 | 01/12/2021 |
| 3.2 | Second Amended and Restated Bylaws of the Registrant | 8-K | 001-39252 | 3.1 | 06/25/2024 |
| 4.1 | Specimen Class A Common Stock Certificate of the Registrant | S-4/A | 333-249558 | 4.5 | 11/20/2020 |
| 4.2 | Specimen Class B Common Stock Certificate of the Registrant | S-4/A | 333-249558 | 4.6 | 11/20/2020 |
| 4.3 | Description of Securities | 10-K | 001-39252 | 4.3 | 02/28/2022 |
| 10.1* | Form of Indemnification Agreement | 8-K | 001-39252 | 10.2 | 01/12/2021 |
| 10.2* | Amended and Restated 2014 Equity Incentive Plan, and forms of agreement thereunder | S-4 | 333-249558 | 10.15 | 10/20/2020 |
| 10.3* | 2020 Equity Incentive Plan and forms of agreement thereunder | 8-K | 001-39252 | 10.4 | 01/12/2021 |
| 10.4* | 2020 Employee Stock Purchase Plan | 8-K | 001-39252 | 10.5 | 01/12/2021 |
| 10.5* | Management Incentive Plan | 8-K | 001-39252 | 10.6 | 01/12/2021 |
| 10.6* | Executive Incentive Bonus Plan | 8-K | 001-39252 | 10.7 | 01/12/2021 |
| 10.7* | Employment Agreement, effective as of December 31, 2021, between the Registrant and Jamie L. Reynoso | 10-K | 001-39252 | 10.12 | 02/28/2022 |
| 10.8* | Employment Agreement, effective as of April 29, 2024, between the Registrant and Peter Kuipers | 10-Q | 001-39252 | 10.1 | 11/08/2024 |
| 10.9* | Employment Agreement, effective as of May 9, 2022, between the Registrant and Aric Sharp | 10-Q | 001-39252 | 10.2 | 08/08/2022 |
| 10.10* | Employment Agreement, effective as of July 18, 2022, between the Registrant and Brady Priest | 10-K | 001-39252 | 10.14 | 03/01/2023 |
| 10.11* | Employment Agreement, dated as of August 8, 2022, between the Registrant and Andrew Toy | 10-Q | 001-39252 | 10.1 | 11/07/2022 |
| 10.12* | Amended and Restated Director Compensation Policy | 10-Q | 001-39252 | 10.1 | 05/07/2024 |
| 10.13* | Board Observer Agreement, dated as of March 16, 2023, between the Registrant and Zach Weinberg. | 8-K | 001-39525 | 10.1 | 03/17/2023 |
| 10.14* | Employment Agreement, dated as of February 24, 2022, between the Registrant and Conrad Wai | 10-Q | 001-39252 | 10.2 | 05/09/2023 |
| 10.15* | Employment Agreement, dated as of March 8, 2024, between the Registrant and Karen Soares. | 10-K | 001-39252 | 10.16 | 03/14/2024 |
| 10.16* | Agreement for the Provision of Interim Management Service, dated as of December 22, 2023 between the Registrant and AP Services, LLC. | 10-K | 001-39252 | 10.17 | 03/14/2024 |
| 19 | Insider Trading Policy | 10-K | 001-39252 | 19 | 03/3/2025 | |
| 21 | List of Subsidiaries | X | ||||
| 23 | Consent of Independent Registered Public Accounting Firm | X | ||||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 31.2 | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.1 | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.2 | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 97 | Clover Health Investments, Corp. Clawback Policy | 10-K | 001-39252 | 97.1 | 03/14/2024 | |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. | |||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||
- Indicates a management contract or compensatory plan or arrangement.
** Schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The registrant hereby agrees to furnish supplementary a copy of any omitted schedule to the SEC upon its request.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.